Altria Has Better Dividend Coverage Than Clorox, With a Different Risk

Altria's dividend starts from a stronger cash position than Clorox's. The tobacco company raised its quarterly payout to $1.11 in August, or $4.44 annually, and narrowed 2026 adjusted EPS guidance to $5.61 to $5.72. First-half adjusted EPS rose 4.9%, leaving the dividend covered by earnings even as cigarette volumes decline.

Clorox offers a lower yield and weaker recent cash coverage. Fiscal 2026 free cash flow of $405 million fell short of $602 million in dividends. Management expects that imbalance to ease as working capital and investment normalize, and it forecasts 3.5% to 4.5% organic sales growth in fiscal 2027. The case therefore rests on a recovery that has not yet appeared in free cash flow.

The tradeoff is not simply payout safety. Altria's core combustible business is shrinking, regulation can alter product economics, and its transition toward smoke-free products remains uncertain. A covered dividend can still become harder to grow if volumes erode faster than pricing and cost control can compensate.

Clorox sells products with steadier long-term demand and fewer regulatory constraints, but it is working through logistics costs, leverage and the integration of acquired brands. Its balance-sheet and cash-conversion problems are more immediate.

Altria offers stronger present coverage; Clorox offers less regulatory risk but needs a sharper cash-flow recovery. For investors focused on the next several years of income, Altria's numbers are more supportive. For investors unwilling to own tobacco, Clorox may be acceptable only if quarterly cash flow begins to confirm management's fiscal 2027 targets.